Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis

INTRODUCTION: Hyperkalemia risk is increased in diabetes, particularly in patients with renal impairment or those receiving angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) or potassium-sparing diuretics. Conversely, other diuretics can increase hypokalemia risk....

Descripción completa

Detalles Bibliográficos
Autores principales: Yavin, Yshai, Mansfield, Traci A., Ptaszynska, Agata, Johnsson, Kristina, Parikh, Shamik, Johnsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801817/
https://www.ncbi.nlm.nih.gov/pubmed/26758563
http://dx.doi.org/10.1007/s13300-015-0150-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801817/
https://www.ncbi.nlm.nih.gov/pubmed/26758563
http://dx.doi.org/10.1007/s13300-015-0150-y

Ejemplares similares